Yehao Zhang

582 total citations
41 papers, 423 citations indexed

About

Yehao Zhang is a scholar working on Neurology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Yehao Zhang has authored 41 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 16 papers in Molecular Biology and 12 papers in Complementary and alternative medicine. Recurrent topics in Yehao Zhang's work include Neurological Disease Mechanisms and Treatments (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Traditional Chinese Medicine Analysis (7 papers). Yehao Zhang is often cited by papers focused on Neurological Disease Mechanisms and Treatments (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Traditional Chinese Medicine Analysis (7 papers). Yehao Zhang collaborates with scholars based in China, Australia and United States. Yehao Zhang's co-authors include Mingjiang Yao, Jianxun Liu, Jianxun Liu, Bin Yang, Xinming Li, Li Xu, Xiaodi Fan, Yongqiu Zheng, Wenting Song and Wenhui Zhang and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Journal of Ethnopharmacology.

In The Last Decade

Yehao Zhang

37 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yehao Zhang China 10 150 142 81 42 42 41 423
Haiyan Zhu China 11 153 1.0× 116 0.8× 91 1.1× 22 0.5× 24 0.6× 30 397
Tongtong Xu China 8 176 1.2× 222 1.6× 42 0.5× 44 1.0× 42 1.0× 14 449
Yu Liang China 12 123 0.8× 76 0.5× 34 0.4× 34 0.8× 45 1.1× 18 400
Qing Ye China 15 183 1.2× 81 0.6× 48 0.6× 41 1.0× 47 1.1× 35 516
Ruixia Deng Hong Kong 11 181 1.2× 47 0.3× 75 0.9× 24 0.6× 34 0.8× 18 501
Xiaopeng Shi China 10 197 1.3× 48 0.3× 64 0.8× 29 0.7× 24 0.6× 47 479
Daniela Elisabeth Eigenmann Switzerland 8 165 1.1× 201 1.4× 38 0.5× 59 1.4× 14 0.3× 11 499
Liu Tu China 8 171 1.1× 52 0.4× 53 0.7× 16 0.4× 29 0.7× 12 364

Countries citing papers authored by Yehao Zhang

Since Specialization
Citations

This map shows the geographic impact of Yehao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yehao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yehao Zhang more than expected).

Fields of papers citing papers by Yehao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yehao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yehao Zhang. The network helps show where Yehao Zhang may publish in the future.

Co-authorship network of co-authors of Yehao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yehao Zhang. A scholar is included among the top collaborators of Yehao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yehao Zhang. Yehao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Min, Wenting Song, Mingjiang Yao, et al.. (2025). Qilong capsule regulates microglial function and inhibits platelet activation after multiple cerebral infarctions by regulating the P2Y12/AC/cAMP signalling pathway. Journal of Ethnopharmacology. 345. 119586–119586.
2.
Zhang, Yehao, et al.. (2025). Inflammation and platelet hyperresponsiveness in coronary artery disease and the influence of Talin-1/αIIbβ3-mediated bidirectional signaling pathway. Frontiers in Pharmacology. 16. 1535182–1535182. 1 indexed citations
3.
Guo, Hao, Junmei Li, Min Zhan, et al.. (2024). Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway. Chinese Medicine. 19(1). 109–109. 3 indexed citations
4.
Wang, Zihan, Yehao Zhang, Han Peng, et al.. (2024). Mitophagy in ischemic heart disease: molecular mechanisms and clinical management. Cell Death and Disease. 15(12). 934–934. 9 indexed citations
5.
Zheng, Xiaoyu, Hongwei Zhang, Yehao Zhang, et al.. (2024). Salidroside ameliorates cerebral ischemic injury and regulates the glutamate metabolism pathway in astrocytes. Frontiers in Pharmacology. 15. 1472100–1472100. 2 indexed citations
6.
Han, Xiao, Yehao Zhang, Yuanyuan Chen, et al.. (2024). Hydroxysafflor Yellow A Inhibits Pyroptosis and Protecting HUVECs from OGD/R via NLRP3/Caspase-1/GSDMD Pathway. Chinese Journal of Integrative Medicine. 30(11). 1027–1034. 5 indexed citations
7.
Yao, Mingjiang, et al.. (2024). Panax notoginseng saponins stimulates the differentiation and neurite development of C17.2 neural stem cells against OGD/R injuries via mTOR signaling. Biomedicine & Pharmacotherapy. 172. 116260–116260. 6 indexed citations
8.
9.
Fan, Xiaodi, et al.. (2023). The glymphatic system: a new perspective on brain diseases. Frontiers in Aging Neuroscience. 15. 1179988–1179988. 33 indexed citations
10.
Zhang, Yehao, et al.. (2022). [Protection of salidroside on endothelial cell barrier in cerebral ischemia-reperfusion model rats].. PubMed. 47(19). 5284–5291. 2 indexed citations
11.
Zhang, Yehao, Lan Miao, Qing Peng, et al.. (2022). Parthenolide modulates cerebral ischemia-induced microglial polarization and alleviates neuroinflammatory injury via the RhoA/ROCK pathway. Phytomedicine. 105. 154373–154373. 34 indexed citations
12.
Liu, Nan, Guozhi Jiang, Li Xu, et al.. (2022). Combination of panax ginseng and ginkgo biloba extracts attenuate cerebral ischemia injury with modulation of NLRP3 inflammasome and CAMK4/CREB pathway. Frontiers in Pharmacology. 13. 980449–980449. 8 indexed citations
13.
Zheng, Xiaoyu, et al.. (2022). Research Progress on the Pharmacological Mechanisms of Chinese Medicines that Tonify Qi and Activate Blood Against Cerebral Ischemia/Reperfusion Injury. World Journal of Traditional Chinese Medicine. 8(2). 225–235. 6 indexed citations
14.
Fan, Xiaodi, Mingjiang Yao, Bin Yang, et al.. (2021). Chinese Herbal Preparation SaiLuoTong Alleviates Brain Ischemia via Nrf2 Antioxidation Pathway–Dependent Cerebral Microvascular Protection. Frontiers in Pharmacology. 12. 748568–748568. 9 indexed citations
15.
Ma, Bo, Li Xu, Mingjiang Yao, et al.. (2021). Jiedu Tongluo Granules Ameliorates Post-stroke Depression Rat Model via Regulating NMDAR/BDNF Signaling Pathway. Frontiers in Pharmacology. 12. 662003–662003. 18 indexed citations
16.
Luo, Chenxi, Yehao Zhang, Hao Guo, et al.. (2020). Ferulic Acid Attenuates Hypoxia/Reoxygenation Injury by Suppressing Mitophagy Through the PINK1/Parkin Signaling Pathway in H9c2 Cells. Frontiers in Pharmacology. 11. 103–103. 35 indexed citations
17.
Zhang, Yehao, Jianxun Liu, Mingjiang Yao, et al.. (2019). Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced Neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression. Oxidative Medicine and Cellular Longevity. 2019. 1–13. 25 indexed citations
18.
19.
Zhang, Yehao, Jianxun Liu, Bin Yang, et al.. (2018). Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke. Frontiers in Pharmacology. 9. 518–518. 69 indexed citations
20.
Zhang, Yehao, Weihong Cong, Bin Yang, et al.. (2015). Effect of Sailuotong capsule on mitochondrial dynamics in focal cerebral ischemia/reperfusion rats. China Journal of Chinese Materia Medica. 40(10). 1984–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiyan Zhu Breakdown of academic impact, for papers by Tongtong Xu Breakdown of academic impact, for papers by Yu Liang Breakdown of academic impact, for papers by Qing Ye Breakdown of academic impact, for papers by Ruixia Deng Breakdown of academic impact, for papers by Xiaopeng Shi Breakdown of academic impact, for papers by Daniela Elisabeth Eigenmann Breakdown of academic impact, for papers by Liu Tu
Rankless by CCL
2026